Nab-Paclitaxel Added To Gemcitabine And Epirubicin Shows Potential As Neoadjuvant Tre
 

SAN ANTONIO - NabTM-paclitaxel (Abraxane), used in tandem with gemcitabine and epirubicin, is showing good anti-tumor activity and tolerability as neoadjuvant treatment for women with locally advanced breast cancer, according to phase II results released at the 2008 San Antonio Breast Cancer Symposium (SABCS).

More...